as 04-24-2025 4:00pm EST
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
Founded: | 1981 | Country: | United States |
Employees: | N/A | City: | LANSING |
Market Cap: | 3.2B | IPO Year: | 1989 |
Target Price: | $9.00 | AVG Volume (30 days): | 9.0M |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.24 | EPS Growth: | N/A |
52 Week Low/High: | $3.87 - $18.58 | Next Earning Date: | 04-09-2025 |
Revenue: | $905,996,000 | Revenue Growth: | -2.50% |
Revenue Growth (this year): | -0.58% | Revenue Growth (next year): | 3.37% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Tobin James P | NEOG | Director | Apr 22 '25 | Buy | $4.73 | 10,000 | $47,268.00 | 37,474 | |
CAPELLO JEFFREY D | NEOG | Director | Apr 22 '25 | Buy | $4.84 | 20,712 | $100,217.08 | 26,629 | |
RODRIGUEZ RAFAEL A | NEOG | Director | Apr 22 '25 | Buy | $4.59 | 7,474 | $34,305.66 | 14,948 |
NEOG Breaking Stock News: Dive into NEOG Ticker-Specific Updates for Smart Investing
Argus Research
2 days ago
Argus Research
2 days ago
StockStory
3 days ago
StockStory
3 days ago
Insider Monkey
3 days ago
MT Newswires
4 days ago
Business Wire
4 days ago
StockStory
4 days ago
The information presented on this page, "NEOG Neogen Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.